January 30, 2018
The Pharmaceutical Information Exchange Act, H.R. 2026, would ease current communication restrictions, permitting drug and medical device companies to discuss off-label information with health insurers. The bill recently passed out of Congress’ Energy and Commerce health subcommittee.
January 4, 2017
New polling data from The Boston Globe reveals that U.S. physicians are prescribing fewer opioids. But how does the trend impact patients – and the nation’s opioid addiction epidemic?
July 27, 2016
Access to comprehensive information about a medication can keep physicians informed and yield better health care decisions, argues a new set of principles from the Biotechnology Innovation Organization and the Pharmaceutical Research and Manufacturers of America. And having better-informed physicians could be good news for patients.
March 24, 2016
Clinical practice guidelines are intended to optimize patient care, explains a new policy brief from the Institute for Patient Access.
March 23, 2016
By David Charles, MD and Mary Ann Chapman, PhD When patients experience health problems, they trust their physicians to recommend…
May 23, 2015
By David Charles, MD and Mary Ann Chapman, PhD Every prescription medication approved in the United States is accompanied by…
November 7, 2014
When the American Medical Association gathers this weekend in Dallas, the House of Delegates will consider a resolution with real-world implications for how much – and what sort – of information physicians can access about the medications they prescribe.
